Clinical trials
Active, not recruiting Carcinoma, Transitional Cell trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Exelixis | 1 |
| Genentech, Inc. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| The Netherlands Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 6 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.